All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

David Cooke, MD
Disclosure(s): AstraZeneca: Advisory Board (Ongoing); Bristol Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Sara Pereira, MD

Presentations

1. Introduction: Where Were We Then, Where Are We Now?
   Robert S.D Higgins, MD,MSHA
    
2. Equity in Standard of Care Treatment -- Patient Navigation in Lung Cancer
   Brendon Stiles, MD
   Disclosure(s): Medtronic: Consultant (Ongoing), Speaker (Ongoing); American Cancer Society: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Arcus Biosciences: Advisory Board (Terminated); Astra Zeneca: Advisory Board (Ongoing), Consultant (Ongoing); BMS: Advisory Board (Ongoing); BMS Foundation: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Galvanize Therapeutics Inc: Consultant (Ongoing); Lung Cancer Research Foundation: Board member (Ongoing); Merck & Co.: Advisory Board (Ongoing), Consultant (Ongoing); Pfizer, USA: Advisory Board (Ongoing), Consultant (Ongoing); Regeneron: Consultant (Ongoing); Roche Genentech: Advisory Board (Ongoing), Consultant (Ongoing); Xalud Therapeutics: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
    
3. Taking Action Against HOCM in Minority Patients
   Jacques Kpodonu, MD
    
4. The STS Congenital Database -- Our Tool to Achieve Health Equity
   Glenn J. Pelletier, MD, MBA
    
5. Panel Discussion and Audience Q&A
   Rian M. Hasson, MD, MPH, FACS
   
   Errol L. Bush, MD
   Disclosure(s): Johnson & Johnson Ethicon: Advisory Board (Terminated, April 30, 2022)
   
   Loretta Erhunmwunsee, MD
   Disclosure(s): Astrazeneca: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker (Ongoing); Gilead Oncology: Speaker (Terminated); IDEOlogy Health: Consultant (Terminated)
    
6. Workforce Equity: High School Recruitment
   Ikenna C. Okereke, MD
    
7. Workforce Equity: Building an Environment of Belonging for Our Trainees
   Cherie Erkmen, MD
    
8. Workforce Equity: Cultivating the Physicians Our Nation Desperately Needs
   Mark C. Henderson, MD
    
9. Panel Discussion and Audience Q&A
   DuyKhanh P. Ceppa, MD
   Disclosure(s): Medtronic: Consultant (Ongoing); Astra Zeneca: Advisory Board (Ongoing), Consultant (Ongoing); Cook Medical: Consultant (Ongoing)
   
   Benjamin Haithcock, MD